The role of RIFINs and their interaction with blood type in vulnerability to severe malaria in Malian children
RIFIN 的作用及其与血型的相互作用在马里儿童易患严重疟疾方面的作用
基本信息
- 批准号:10223427
- 负责人:
- 金额:$ 4.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-16 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:ABO blood group systemAcuteAdhesivesAffectAfrica South of the SaharaAlgorithmsAnemiaAntibodiesAntigensBindingBioinformaticsBloodCase Fatality RatesCase-Control StudiesCellsCessation of lifeChildComaComplexCustomDataDevelopmentDiseaseDisease OutcomeEndothelial CellsEpidemiologic MethodsErythrocytesFamilyFunctional disorderGenesGoalsGrantHigh-Throughput Nucleotide SequencingImmuneImmune responseImmunityImpairmentIn VitroIndividualInfectionInfectious Disease EpidemiologyInfectious Diseases ResearchLinkMalariaMaliMediatingMicroarray AnalysisNatural ImmunityParasitemiaParasitesPathogenesisPhysiciansPlasmodium falciparumPlayPredispositionProcessProtein MicrochipsProteinsReceptor CellResearchRoleSamplingScientistSerumShapesSiteSpleenSubgroupSurfaceSurface AntigensSymptomsTechnologyTissuesTrainingTranscriptVaccine DesignVaccinesVariantVirulence FactorsWorkacquired immunitycareerdifferential expressionexperiencegenomic epidemiologyimmune activationimprovedmalaria infectionnext generationpreferencepreventpublic health interventionreceptorreference genomesequencing platformskillstranscriptome sequencingtranscriptomics
项目摘要
PROJECT SUMMARY/ABSTRACT
Plasmodium falciparum causes nearly 435,000 deaths annually worldwide. Victims of severe malaria are
predominantly sub-Saharan children, who may present with symptoms of severe anemia or unarousable coma.
The pathogenesis of severe malaria is poorly understood but mediated by the expression of adhesive variant
surface antigens (VSAs) on infected red blood cells. These VSAs are involved in sequestration and rosetting,
unique virulence factors that allow the parasite to evade host immune responses and prevent clearance in the
spleen. In particular, ABO blood groups are critical for rosetting, which is the spontaneous binding of infected
and uninfected erythrocytes together. Individuals with blood type A are particularly vulnerable to severe malaria,
unlike those with blood type O who appear relatively protected against severe disease. A relatively unstudied
family of VSAs, the repetitive interspersed family (RIFIN) proteins, have been recently found to be important in
rosetting. RIFINs preferentially bind blood type A antigens, forming larger and tighter rosettes than in blood type
O. RIFINs may mediate the association between ABO blood type and severe malaria susceptibility; these
proteins also appear to be targets for protective immunity. Humoral immune responses against RIFINs have
been correlated with asymptomatic infections. As such, we posit that a subset of RIFINs play a critical role in
severe malaria pathogenesis and that individuals who lack immunity to this subset are the most susceptible to
develop severe malaria. In a case-control study that began in Mali in 2014, our group collected blood and serum
samples from severe malaria cases and matched controls with uncomplicated malaria. Here, we propose to
identify and sequence RIFINs expressed in severe malaria using next-generation RNA-sequencing technologies.
Using a custom protein microarray, we will then determine whether a lack of antibodies to these RIFIN proteins
is associated with developing severe disease. In Aim 1, we will identify subgroups of RIFIN transcripts that are
differentially expressed in subjects with severe malaria versus matched controls with uncomplicated malaria via
RNA-Seq. We hypothesize that a subset of RIFIN-As will be predominantly expressed in severe malaria cases
with blood type A, in contrast to expression of a heterogeneous group of RIFIN-As in other infections. In Aim 2,
we will use the predominant RIFIN transcripts identified in Aim 1 and other parasite antigens to populate a custom
protein microarray in order to define a subset of RIFIN proteins associated with increased vulnerability to severe
malaria. We hypothesize that sera from children acutely ill with severe malaria will recognize fewer RIFIN proteins
on a protein microarray and react to them less intensely than their convalescent sera and sera from matched
controls with uncomplicated malaria, particularly for severe malaria cases with blood type A. The candidate will
gain valuable expertise in bioinformatics analysis, particularly from microarrays and transcriptomic data from
high-throughput sequencing platforms; use epidemiological techniques to conduct translational infectious
disease research; and apply these skills to support effective public health interventions such as a vaccine.
项目总结/摘要
恶性疟原虫每年在全世界造成近43.5万人死亡。严重疟疾的受害者是
主要是撒哈拉以南地区的儿童,他们可能会出现严重贫血或无法唤醒的昏迷症状。
重症疟疾的发病机制知之甚少,但通过粘附变体的表达介导
受感染红细胞表面抗原(VSA)。这些VSA参与隔离和玫瑰花结,
独特的毒力因子,使寄生虫逃避宿主的免疫反应,并防止清除在
脾脏特别是,ABO血型对玫瑰花结至关重要,玫瑰花结是感染的
和未感染的红细胞。A型血的人特别容易患上严重的疟疾,
不像O型血的人,他们似乎对严重的疾病有相对的保护。一个相对未经研究的
最近发现,VSA家族,即重复散布家族(RIFIN)蛋白,在
玫瑰花结RIFIN优先结合A型血型抗原,形成比A型血型更大、更紧的玫瑰花结
O. RIFIN可能介导ABO血型和严重疟疾易感性之间的关联;这些基因可能是一种免疫调节因子。
蛋白质似乎也是保护性免疫的目标。针对RIFIN的体液免疫应答
与无症状感染有关。因此,我们认为RIFIN的一个子集在以下方面发挥着关键作用:
严重的疟疾发病机制,缺乏对该亚群免疫力的个体最容易感染
患上严重的疟疾在2014年开始于马里的一项病例对照研究中,
严重疟疾病例的样本和匹配的无并发症疟疾对照。在此,我们建议
使用下一代RNA测序技术鉴定和测序在严重疟疾中表达的RIFIN。
使用定制的蛋白质微阵列,我们将确定是否缺乏这些RIFIN蛋白的抗体,
与严重疾病的发展有关。在目标1中,我们将确定RIFIN转录本的亚组,
在严重疟疾受试者与匹配的无并发症疟疾对照者中的差异表达,
RNA测序我们假设RIFIN-As的一个子集将主要在严重疟疾病例中表达,
与其他感染中RIFIN-As异质组的表达相反。在目标2中,
我们将使用在Aim 1和其他寄生虫抗原中鉴定的主要RIFIN转录物来填充定制的
蛋白质微阵列,以确定与严重的易感性增加相关的RIFIN蛋白质的子集,
疟疾我们假设,患有严重疟疾的儿童急性病患者的血清将识别较少的RIFIN蛋白
在蛋白质微阵列上,与他们的恢复期血清和来自匹配的血清相比,
控制无并发症的疟疾,特别是A型血的严重疟疾病例。候选人将
获得生物信息学分析的宝贵专业知识,特别是来自微阵列和转录组数据的
高通量测序平台;使用流行病学技术进行翻译感染
疾病研究;并应用这些技能来支持有效的公共卫生干预措施,如疫苗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Albert E Zhou其他文献
Albert E Zhou的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Albert E Zhou', 18)}}的其他基金
The role of RIFINs and their interaction with blood type in vulnerability to severe malaria in Malian children
RIFIN 的作用及其与血型的相互作用在马里儿童易患严重疟疾方面的作用
- 批准号:
10012761 - 财政年份:2019
- 资助金额:
$ 4.78万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 4.78万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 4.78万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 4.78万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 4.78万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 4.78万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 4.78万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 4.78万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 4.78万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 4.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 4.78万 - 项目类别:
Operating Grants